FIELD: chemistry.
SUBSTANCE: invention relates to use N,N-complex of dichlorodi-[3,5-dimethyl-4-((benzylsulfanyl)methyl)-1H-pyrazole]dihydrate of copper (II) of formula (1)
as an α-amylases enzyme inhibitor.
EFFECT: said compound exhibits inhibitory activity on the α-amylase enzyme and can be used as a biologically active substance having hypoglycemic activity.
1 cl, 2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING N,N-COMPLEXES OF DICHLORODI-[3,5-DIMETHYL-4-(SULFANYLMETHYL)-1H-PYRAZOLE]COPPER DIHYDRATE (II) | 2017 |
|
RU2677484C2 |
| N,N-COMPLEXES OF DICHLORODI-[3,5-DIMETHYL-4-(SULPHANYLMETHYL)-1H-PYRAZOLE]DIHYDRATE OF COPPER (II), HAVING FUNGICIDAL ACTIVITY AGAINST CANDIDA ALBICANS FUNGUS | 2017 |
|
RU2708086C2 |
| WATER-SOLUBLE CIS-S, S-COMPLEX DIACETATE [DI-1,6- (3,5-DIMETHYLISOXAZOL-4-YL) -2,5-DITHIAHEXANE] PALLADIUM (II), HAVING INHIBITORY ACTIVITY ON THE ENZYME Α-AMYLASE | 2019 |
|
RU2709512C1 |
| N,N'-COMPLEX OF DIBROMODI-[(4-(BENZYLSULFANYL)METHYL-3,5-DIMETHYL-1N-PYRAZOLE]PALLADIUM(II) EXHIBITING ANTINEOPLASTIC ACTIVITY | 2018 |
|
RU2703536C1 |
| METHOD FOR PREPARING N-COMPLEXES OF DICHLORODI-[(4-(BENZYLSULFANYL)METHYL)-3,5-DIMETHYL-1H-PYRAZOLE]PALLADIUM (II) AND PLATINUM (II) | 2017 |
|
RU2672265C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS FOR CANCER TREATMENT | 2007 |
|
RU2449788C2 |
| N-PIPERIDIN-3-YL-BENZAMIDE DERIVATIVES FOR CARDIOVASCULAR DISEASES TREATMENT | 2014 |
|
RU2618628C1 |
| TRAF 6 INHIBITORS | 2017 |
|
RU2770404C2 |
| 3-ACYLAMINOPYRIDIN DERIVATIVES, APPLICABLE AS SERINE-THREONINE PROTEINKINASE GSK3B INHIBITORS, AS MEDICATIONS FOR TYPE II DIABETES TREATMENT | 2013 |
|
RU2570907C2 |
| METHOD FOR SYNTHESIS OF 2-CARBOXY-N,N,N-TRIMETHYLETHANAMINIUM DERIVATIVE | 2021 |
|
RU2786884C2 |
